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ess: oguzuzun67@yahooSummary Ankylosing spondylitis (AS) is a chronic seronegative spondyloarthritis
with the major histocompatibility antigen HLA B27. Pulmonary involvement in AS is
rare and is usually in the form of upper lobe fibrocavitary disease. Herein, we
present a case with recurrent pleural and pericardial effusion without apical
fibrobullous disease who responded to prednisolone treatment well. It is believed
that this is the first case report complicating AS without parenchymal involvement in
the literature.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Upper lobe fibrocavitary disease is most common
pulmonary manifestation of ankylosing spondylitis
(AS).1 Other forms of pleuropulmonary manifesta-
tion is rare. We present a case of AS with pleural
and pericardial effusion who responded well to
systemic prednisolone treatment.Case report
A 57-year-old teacher presented with dyspnea,
pleuritic chest-pain on his left hemithorax and
fever which had began 20 days ago and hadElsevier Ltd. All rights reserve
4590767;
.com.tr (O. Uzun).gradually improved. He was an ex-smoker of 15 p/y
who stopped smoking 15 years ago. He denied any
hemoptysis, cough and weight loss. His past-
medical history revealed that he was diagnosed as
AS 6 months ago when he had a back-pain and also
peripheral arthritis. At that time, an ophthalmol-
ogist revealed an uveitis. He has been on sulfasa-
lazine and local steroid eye-drop treatment since
then. On admission, he was anxious and mildly
dyspneic with a pulse rate of 95/min, respiratory
rate of 24/min and a blood pressure of 130/
80mmHg. His breath sounds were diminished in
the left lower-zone and flatness was remarkable on
percussion on that side. Spinal movements were
mildly restricted in all directions. Rest of his
examination was normal. During his stay in hospi-
tal, his temperature increased to 38–39 1C several
times a day. His chest X-ray was compatible with a
pleural effusion on the left side showing and.
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Figure 2 Pelvic and spine X-ray of the patient showing
obliteration of the sacroiliac joint and calcification of the
anterior longitudinal ligament.
Figure 1 Ches X-ray of the patient compatible with left
pleural effusion.
Figure 3 Thorax CT of the patient showing pleural and
pericardial effusion (a) without any parenchymal invol-
vement (b).
Isolated pleural and pericardial effusion 357homogenous opacity obscuring left costophrenic
angle (Fig. 1). Obliteration of his sacroiliac joints as
well as calcification of the anterior longitudinal
ligament was remarkable on his pelvic and spine
X-rays (Fig. 2). Laboratory investigations showed:
haemoglobin 12 g/dl, white blood cell-count
12,000/mm3, with 75% neutrophils, 19% lympho-
cytes, 7% monocytes and 3% eosinophils. Erythro-
cytes sedimentation rate was 86mm/h. Electrolyte
levels, urine analysis renal and liver function tests
were all within normal limits. No bacterial growth
observed on urine and blood cultures. Antinuclear
antibody was positive in low titers, and rheumatoid
factor and anti-double-strand DNA were negative.
Pleural fluid aspiration revealed an exudative
effusion with a LDH of 500 IU/dl, glucose level of
50mg/dl and total protein of 4 g/dl. Tubercle
bacilli were not seen in the fluid. Then, a closed
pleural biopsy was performed which showed
chronic pleuritis with a predominantly lymphocytic
inflammation. Meanwhile, sefuoksime IV 750mg tid
and clarithromysin 500mg BID were begun with a
probable diagnosis of parapneumonic effusion. His
symptoms improved gradually, sedimentation rate
dropped to 60mm/Hg, fever disappeared and his
chest X-ray was cleared. He is discharged from the
hospital 1 week later with a recommendation of
clarithromysin 500mg BID one more week.
Twenty days later from his discharge, he returned
with the same complaints as left-side chest pain,
fever and malaise. This time, pericardial rub was
also remarkable on cardiac examination which
echocardiography revealed 10mm-thickness peri-
cardial effusion, later. His pleural effusion had also
recurred on his chest X-ray. However, no parench-
ymal involvement was remarkable on thorax CT
(Fig. 3a and b). No tuberculous bacilli growth was
observed on culture since the previous investiga-tion. IgG, IgA, IgE and IgM and complement 3 and 4
levels were normal. He was positive for HLA-B27
antigen. Neither malignant cell infiltration
nor granulamatous infiltration of the pleura was
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This time, prednisolone 60mg daily was begun with
a diagnosis as spondylitic pleural and pericardial
effusion. He responded quickly to treatment and all
his symptoms completely resolved within a few
days. Pleural and pericardial effusion completely
resolved on chest X-ray and echocardiography 1
week later. Steroid-dose gradually tapered to
10mg. Two years after he presented, the patient
remains well off all medications.Discussion
AS is chronic inflammatory disease of the axial
skeleton manifested by back pain and progressive
stiffness of the spine. AS is one of the spondyloar-
thropathies which show inflammation around the
enthesis (the site of ligament insertion into bone).
It characteristically affects young adults with a
peak age of onset between 20 and 30 years.
Although classically thought of as a spinal disease,
transient acute arthritis of peripheral joints occurs
in up to 50 percent of patients. In addition,
systemic involvement of other organs such as eyes,
lungs and heart can be affected.
Pulmonary involvement in AS is a well-known
feature of the disease. Apical pleural thickening
with underlying apical fibrobullous disease is the
common manifestation.1 The incidence of pleur-
opulmonary involvement shows a big variation in
the literature, probably as a result of selection
biases. While Spencer et al.2 reported the pleur-
opulmonary incidence as 0%, Lauritzen et al.3 found
it to be 30%. Reviewing the radiographs of 2080 AS
patients, Rosenow et al.1 found 26 cases of apical
fibrobullous disease. In five of the patients,
aspergillosis had been complicated fibrobullous
disease some time during the disease course.
Although apicobullous disease can frequently be
seen in AS patients, pleural effusion is a very rare
manifestation of the disease. Rosenow et al.1
reported three cases after reviewing the chest
X-rays and reports of 2080 AS cases (0.15%).Two of
the Rosenow’s cases had apicobullous disease as
well as pleural effusion. One of the cases of
Rosenow et al.1 and another case from Kinnear
and Shneerson4 had only pleural effusion without
apical involvement as in our case. Pleural effusion
can be left-side1,5 or bilateral.1,4,6Although pericardial effusion has been rarely
reported in AS patients,7 to our knowledge, there is
no previous report showing pleural and pericardial
effusion association in AS as manifested in our case.
Pleural fluid analysis of patients with effusion had
no discriminative feature, and is usually exudative
and non-hemorrhagic with normal glucose and pH
levels.
Pleural effusion can clear spontaneously in some
AS patients.1 However, there is usually a need of
systemic or local antiinflammatory treatment as
recurrence may be prominent feature of the
disease as in our case. Systemic prednisolone
(30mg daily),4 local administration of steroids
(20mg prednisolone locally to pleural cavity after
complete drainage of the effusion)5 or phenylbu-
tazone (200mg daily)6 had been successfully used
in the treatment of pleural effusion. We used 60mg
prednisolone daily successfully as our patient had
prominent systemic symptoms.
In summary, we present a case of AS patient who
had polyserositis, namely pleural and pericardial
effusion, and responded well to prednisolone. This
association had not been reported in the literature
and clinician should be aware of this presentation
of AS without apicobullous disease.References
1. Rosenow EC, Strimlan CV, Muhm JR, Ferguson RH. Pleur-
opulmonary manifestations of ankylosing-spondylitis. Mayo
Clin Proc 1977:641–9.
2. Spencer DG, Park WM, Dick HM, Papazoglov N, Buchanan WW.
Radiological manifestations in 200 patients with ankylosing-
spondylitis: correlation with clinical features and HLA B27.
J Rheumatol 1979;6:305–15.
3. Lauritzen H, Medina J, Loken MD, et al. Pulmonary disease in
patients with ankylosing-spondylitis (abstract). Am rev Respir
Dis 1964;98:126.
4. Kinnear WJM, Shneerson JM. Acute pleural effusion in
inactive ankylosing-spondylitis. Thorax 1985;40:150–1.
5. Tanaka H, Itoh E, Shibusa T, Chiba H, Hirasawa M, Abe S.
Pleural effusion in ankylosing spondylitis: successful treat-
ment with intra-pleural steroid administration. Respir Med
1995;89:509–11.
6. Blanch J, Guitierrez-Cobellada J, Lopez-Colomes JL, Faus S,
Martinez-Pordo S. Pleural effusion in ankylosing-spondylitis: a
new pulmonary disease or a casual association? Rev Espan
Rheumatol 1989;16:91–2.
7. Baites JE, Tucker JB, Baldwin JL, Thomas CN. Pericarditis in
ankylosing spondylitis. J Rheumatol 1980;7:929–31.
